Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TNK2 anticorps (pTyr284)

TNK2 Reactivité: Humain, Souris WB, ELISA, IF, IHC (p) Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN6282360
  • Antigène Voir toutes TNK2 Anticorps
    TNK2 (tyrosine Kinase, Non-Receptor, 2 (TNK2))
    Épitope
    • 21
    • 15
    • 13
    • 9
    • 8
    • 8
    • 8
    • 8
    • 7
    • 7
    • 6
    • 6
    • 6
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 220-300, pTyr284
    Reactivité
    • 122
    • 50
    • 46
    • 3
    • 2
    • 2
    Humain, Souris
    Hôte
    • 119
    • 3
    • 1
    Lapin
    Clonalité
    • 121
    • 1
    Polyclonal
    Conjugué
    • 49
    • 11
    • 11
    • 9
    • 8
    • 7
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp TNK2 est non-conjugé
    Application
    • 95
    • 68
    • 26
    • 26
    • 26
    • 20
    • 15
    • 11
    • 8
    • 6
    • 6
    • 4
    • 3
    • 3
    • 2
    • 1
    Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Fonction
    Rabbit polyclonal to Phospho-ACK (Y284).
    Specificité
    Phospho-ACK (Y284) Polyclonal Antibody detects endogenous levels of ACK protein only when phosphorylated at Y284.
    Purification
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
    Immunogène
    Synthesized peptide derived from human ACK around the phosphorylation site of Y284.
    Isotype
    IgG
    Top Product
    Discover our top product TNK2 Anticorps primaire
  • Indications d'application
    WB 1:500-1:2000
    IHC 1:100-1:300
    IF 1:200-1:1000
    ELISA 1:10000
    Commentaires

    The Tyr-284 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages. It also shows a significant increase in expression in prostate cancers during the progressive stages.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C, and avoid repeat freeze-thaw cycles.
  • Antigène
    TNK2 (tyrosine Kinase, Non-Receptor, 2 (TNK2))
    Autre désignation
    ACK (TNK2 Produits)
    Synonymes
    anticorps ACK, anticorps ACK-1, anticorps ACK1, anticorps p21cdc42Hs, anticorps AW552477, anticorps Ack, anticorps Cdgip, anticorps Pyk1, anticorps ack1, anticorps ackb, anticorps tnk2, anticorps tnk2b, anticorps wu:fj16g04, anticorps zgc:154019, anticorps tyrosine kinase non receptor 2, anticorps tyrosine kinase, non-receptor, 2, anticorps tyrosine kinase, non-receptor, 1, anticorps TNK2, anticorps Tnk2, anticorps tnk1
    Poids moléculaire
    120 kDa
    ID gène
    10188
    UniProt
    Q07912
Vous êtes ici:
Support technique